Cholesteryl ester transfer protein (CETP) inhibitors are currently being investigated because
of their ability to increase high-density lipoprotein cholesterol levels. In various metabolic …

Cholesteryl ester transfer protein (CETP) catalyzes the transfer of cholesteryl ester from high-
density lipoprotein (HDL) to apolipoprotein B-containing lipoproteins in exchange for …

Epidemiologic studies have shown that the concentration of high-density lipoprotein
cholesterol (HDL-C) is a strong, independent, inverse predictor of coronary heart disease …

Human and rabbit plasma contain a cholesteryl ester transfer protein (CETP) that promotes
net mass transfers of cholesteryl esters from high density lipoproteins (HDL) to other plasma …

Cholesteryl ester transfer protein (CETP) modulates the transfer of triglycerides and
cholesteryl esters between high-density lipoprotein (HDL) and other lipoproteins fractions …

Despite tremendous progress made in the management of CHD, a significant number of
fatal and nonfatal CHD events still occur, which leads researchers to target other modifiable …

Based on epidemiologic studies conducted throughout the world, it is established that there
is an inverse relationship between high-density lipoprotein cholesterol (HDL-C) and risk for …

Background: Not only hypercholesterolemia, but also low levels of high-density lipoprotein
cholesterol is a critical risk factor for atherosclerosis-related disease. Therefore, there has …

Elevated low-density lipoprotein (LDL) cholesterol and lowered high-density lipoprotein
(HDL) cholesterol are important risk factors for cardiovascular disease. Accordingly, raising …

Pharmacologic inhibitors of the cholesteryl ester transfer protein (CETP) are capable of
increasing HDL cholesterol by 50% to 100% in humans. Despite intriguing antiatherogenic …